BioSpace News Archive

Press Releases

IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial

May 12, 2025
·
19 min read
Press Releases

Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the Society for Investigative Dermatology Annual Meeting

May 12, 2025
·
12 min read
Press Releases

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 12, 2025
·
4 min read
Press Releases

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

May 12, 2025
·
5 min read
Press Releases

Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET

May 12, 2025
·
2 min read
Press Releases

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025
·
11 min read
Press Releases

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

May 12, 2025
·
9 min read
Press Releases

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025

May 12, 2025
·
2 min read
Press Releases

Arcus Biosciences Announces New Employment Inducement Grants - May 9, 2025

May 12, 2025
·
1 min read
Press Releases

Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases

May 12, 2025
·
4 min read